title: A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
authors.affiliation: Albert Einstein Cancer Center, Bronx, NY 10467.
authors.forename: P H
authors.initials: PH
authors.lastname: Wiernik
authors.forename: D C
authors.initials: DC
authors.lastname: Case
authors.forename: P O
authors.initials: PO
authors.lastname: Periman
authors.forename: Z A
authors.initials: ZA
authors.lastname: Arlin
authors.forename: A B
authors.initials: AB
authors.lastname: Weitberg
authors.forename: P S
authors.initials: PS
authors.lastname: Ritch
authors.forename: M B
authors.initials: MB
authors.lastname: Todd
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage / Q000009:adverse effects; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
chemical_list: D003561:Cytarabine; D015255:Idarubicin; D003630:Daunorubicin